Overview
Thorne is a health and wellness company that makes nutritional supplements. It focuses on purity and scientific backing, testing its products to ensure quality and efficacy for consumers. Its products work by delivering carefully studied nutrients and other ingredients in supplements that people take to support their health. Thorne differentiates itself from competitors through a long history dating back to 1984, a strong emphasis on quality and scientific integrity, and rigorous quality controls. In 2023 the company was acquired by L Catterton, moved off public markets, and continues to pursue growth by expanding research and development. The overall goal is to provide reliable, high-quality supplements that people can trust to support their health and well-being.
Work here?Claim your company
Simplify's take
What believers are saying
- Thorne surpassed $500 million revenue in 2025, with 63% direct-to-consumer growth.
- April 2026 women’s health launches expanded addressable demand in perimenopause and libido.
- September 2026 creatine study and athlete partnerships strengthen performance credibility before close.
What critics are saying
- P&G’s $3.8 billion acquisition announced August 4, 2026 can stall on regulatory review.
- Supplement claims face FDA and FTC scrutiny; one labeling mistake triggers recalls and trust damage.
- P&G integration can flatten Thorne’s premium positioning, killing the brand by 2027.
What makes Thorne unique
- Thorne pairs NSF Certified for Sport with vertically integrated South Carolina manufacturing.
- Thorne launched Taia AI wellness advisor and more than 60 certified products by November 2026.
- Thorne’s practitioner-first brand reached seven million consumers and over 800 employees in 2026.
Help us improve and share your feedback! Did you find this helpful?